Table 1.
Survey participants | COVID-19 infections* | Expected duration to re-commence to full capacity (%) | |||||||
Total (n) | April 2, 2020 | April 20, 2020 | Not stopped | <3 months | 3–6 months | 6–12 months | >12 months | Unclear | |
USA | 166 | 74 | 145 | 0% | 65% | 30% | 3% | 0% | 2% |
Japan | 41 | 2 | 9 | 5% | 45% | 31% | 10% | 2% | 7% |
Spain | 37 | 238 | 426 | 0% | 68% | 27% | 0% | 0% | 5% |
Germany | 22 | 78 | 177 | 0% | 41% | 41% | 5% | 14% | 0% |
Italy | 18 | 192 | 302 | 0% | 33% | 61% | 0% | 0% | 6% |
Argentina | 15 | 3 | 7 | 0% | 80% | 20% | 0% | 0% | 0% |
France | 14 | 85 | 233 | 0% | 50% | 43% | 0% | 0% | 7% |
UK | 12 | 45 | 188 | 0% | 0% | 83% | 0% | 0% | 17% |
Brazil | 9 | 4 | 20 | 0% | 44% | 44% | 0% | 11% | 0% |
S. Korea | 9 | 19 | 21 | 44% | 11% | 11% | 22% | 0% | 11% |
India | 8 | 0 | 1 | 0% | 88% | 13% | 0% | 0% | 0% |
Australia | 6 | 20 | 26 | 0% | 0% | 50% | 50% | 0% | 0% |
Canada | 6 | 29 | 100 | 0% | 50% | 17% | 0% | 0% | 33% |
Chile | 6 | 16 | 58 | 0% | 17% | 83% | 0% | 0% | 0% |
Portugal | 6 | 90 | 210 | 0% | 100% | 0% | 0% | 0% | 0% |
Sweden | 6 | 60 | 150 | 0% | 17% | 67% | 17% | 0% | 0% |
Turkey | 6 | 22 | 111 | 0% | 33% | 33% | 33% | 0% | 0% |
Colombia | 5 | 3 | 8 | 0% | 80% | 0% | 20% | 0% | 0% |
Switzerland | 5 | 211 | 311 | 0% | 20% | 60% | 0% | 0% | 20% |
*Confirmed COVID-19 infections per 100 000 inhabitants at the beginning and end of survey period (source: https://coronavirus.jhu.edu/map.html).